Do poor-responder patients benefit from increasing the daily gonadotropin dose during controlled ovarian hyperstimulation for IVF?

J Haas, E Zilberberg, R Machtinger… - Gynecological …, 2015 - Taylor & Francis
We aim to assess the in vitro fertilization-embryo transfer (IVF-ET) outcome in patients
receiving an extremely high 450 daily dose (IU) of gonadotropins during controlled ovarian …

[HTML][HTML] Stop GnRH-agonist combined with multiple-dose GnRH-antagonist protocol for patients with “genuine” poor response undergoing controlled ovarian …

R Orvieto, M Kirshenbaum, V Galiano… - Frontiers in …, 2020 - frontiersin.org
Objective: To examine whether the Stop GnRH-agonist combined with multiple-dose GnRH-
antagonist protocol may improve conventional IVF/intracytoplasmic sperm injection (ICSI) …

[HTML][HTML] What does unexpected suboptimal response during ovarian stimulation suggest, an overlooked group?

B Wang, W Liu, Y Liu, W Zhang, C Ren… - Frontiers in …, 2021 - frontiersin.org
Unlike poor ovarian response, despite being predicted to be normal responders based on
their ovarian reserve markers, many patients respond suboptimally to ovarian stimulation …

Gonadotrophin-releasing hormone agonist protocol of controlled ovarian hyperstimulation as an efficient treatment in Bologna-defined poor ovarian responders

M Stimpfel, E Vrtačnik-Bokal, B Pozlep… - Systems Biology in …, 2016 - Taylor & Francis
In this retrospective study the outcomes of two protocols of controlled ovarian
hyperstimulation and natural cycle in poor ovarian responders defined according to the …

[HTML][HTML] In vitro fertilization outcome in women with diminished ovarian reserve

BH Yun, G Kim, SH Park, EB Noe… - Obstetrics & …, 2017 - synapse.koreamed.org
Objective This study aimed to identify factors that affect in vitro fertilization (IVF) outcomes in
women with diminished ovarian reserve (DOR). Methods We reviewed 99 IVF cycles in 52 …

[HTML][HTML] An observational retrospective cohort trial on 4,828 IVF cycles evaluating different low prognosis patients following the POSEIDON criteria

PE Levi-Setti, I Zerbetto, A Baggiani… - Frontiers in …, 2019 - frontiersin.org
Objective: To study the actual controlled ovarian stimulation (COS) management in women
with suboptimal response, comparing clinical outcomes to the gonadotropins consume …

[HTML][HTML] Cumulative live birth rate and cost-effectiveness analysis of gonadotropin releasing hormone-antagonist protocol and multiple minimal ovarian stimulation in …

Y Liu, R Su, Y Wu - Frontiers in endocrinology, 2021 - frontiersin.org
Background The overall cumulative live birth rate (CLBR) of poor ovarian responders (POR)
is extremely low. Minimal ovarian stimulation (MOS) provides a relatively realistic solution for …

Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis

EM Kolibianakis, CA Venetis, K Diedrich… - Human reproduction …, 2009 - academic.oup.com
BACKGROUND Whether the addition of growth hormone (GH) can improve the probability of
pregnancy in poor responders undergoing ovarian stimulation for in-vitro fertilization (IVF) …

Factors inducing decreased oocyte maturation rate: a retrospective analysis of 20,939 ICSI cycles

Y Lin, P Yang, Y Chen, J Zhu, X Zhang… - Archives of gynecology and …, 2019 - Springer
Purpose Decreased oocyte maturation rate (OMR) is associated with worse clinical
outcomes in IVF/ICSI cycles. The clinical features inducing decreased OMR remain …

[HTML][HTML] How to personalize ovarian stimulation in clinical practice

G Sighinolfi, V Grisendi, A La Marca - Journal of the Turkish …, 2017 - ncbi.nlm.nih.gov
Controlled ovarian stimulation (COS) in in vitro fertilization (IVF) cycles is the starting point
from which couple's prognosis depends. Individualization in follicle-stimulating hormone …